Sort   by:  
 Page size 
UnknownQuantification of the novel N-methyl-d-aspartate receptor ligand [11C]GMOM in man.
Not available
S-EPMC4904354 | biostudies-literature
UnknownTau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study.
Not available
S-EPMC7714680 | biostudies-literature
UnknownThe binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors.
Not available
S-EPMC4220016 | biostudies-literature
UnknownExpanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy.
Not available
S-EPMC8780589 | biostudies-literature
UnknownSynthesis and Preclinical Evaluation of the First Carbon-11 Labeled PET Tracers Targeting Substance P1-7.
Not available
S-EPMC6220361 | biostudies-literature
UnknownTau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer's disease.
Not available
S-EPMC7680306 | biostudies-literature
UnknownRegional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's disease.
Not available
S-EPMC7567681 | biostudies-literature
UnknownFirst in human evaluation of [18F]PK-209, a PET ligand for the ion channel binding site of NMDA receptors.
Not available
S-EPMC6063804 | biostudies-literature
UnknownDifferential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease.
Not available
S-EPMC9016024 | biostudies-literature
UnknownSynthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor.
Not available
S-EPMC10873260 | biostudies-literature
Sort   by:  
 Page size